Nifty

:

25149.85

Sensex

:

82500.47

-205.40 (-0.81%)
-689.81 (-0.83%)

Login

Nifty
Sensex

:
:

25149.85
82500.47

-205.40 (-0.81%)
-689.81 (-0.83%)

Panacea Biotec Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 531349 | NSE: PANACEABIO

Watchlist

NSE BSE

416.15

11-Jul-2025

Open
High
Low
Previous Close

411
429
408.7
408.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

264517
111400669.75
581.9
130

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,552.93
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,719.22
N/A
3.06

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-2.04
0.55
-5.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-14.46
7.10
8.73

PAT CAGR (%)

10 Years
5 Years
3 Years

-35.95
-64.04
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-0.27
4.46
1.60

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-242.03
-385.57
-641.01

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS -0.19
P/E Ratio -1315.26
Revenue 559
EBITDA -20
Net Income -1
ROA -0.1
P/B Ratio 4.65
ROE -0.14
FCFF -72
FCFF Yield -2.27
Net Debt -159
BVPS 53.74

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 67.90 80.37 -15.52% 108.43 95.23 13.86% 76.64 94.59 -18.98% 56.88 89.41 -36.38%
Expenses 86.47 89.61 -3.50% 93.04 88.59 5.02% 69.90 84.63 -17.41% 67.37 82.60 -18.44%
EBITDA -18.57 -9.24 - 15.39 6.64 131.78% 6.74 9.96 -32.33% -10.49 6.81 -
EBIDTM -27.35% -11.50% 14.19% 6.97% 8.79% 10.53% -18.44% 7.62%
Other Income 6.09 16.39 -62.84% 3.32 3.05 8.85% 3.41 2.13 60.09% 3.80 3.34 13.77%
Interest 4.64 3.36 38.10% 3.85 3.41 12.90% 3.76 3.55 5.92% 3.21 3.46 -7.23%
Depreciation 4.91 5.14 -4.47% 5.21 5.21 0.00% 5.09 5.34 -4.68% 5.08 5.40 -5.93%
PBT -22.03 -1.35 - 9.65 1.07 801.87% 1.30 3.20 -59.38% -14.98 1.29 -
Tax -9.64 0.02 - 0.00 0.64 -100.00% 0.01 0.00 0 -1.20 0.00 -
PAT -12.39 -1.37 - 9.65 0.43 2,144.19% 1.29 3.20 -59.69% -13.78 1.29 -
PATM -18.25% -1.70% 8.90% 0.45% 1.68% 3.38% -24.23% 1.44%
EPS -2.02 -0.22 - 1.57 0.07 2,142.86% 0.21 0.52 -59.62% -2.25 0.21 -

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 132.53 136.46 -2.88% 163.49 150.50 8.63% 147.35 143.02 3.03% 115.72 129.19 -10.43%
Expenses 159.41 142.50 11.87% 155.53 150.65 3.24% 140.35 146.58 -4.25% 129.71 139.50 -7.02%
EBITDA -26.88 -6.04 - 7.96 -0.15 - 7.00 -3.56 - -13.99 -10.31 -
EBIDTM -20.28% -4.43% 4.87% -0.10% 4.75% -2.49% -12.09% -7.98%
Other Income 8.59 10.81 -20.54% 3.62 5.68 -36.27% 4.65 3.23 43.96% 3.80 6.08 -37.50%
Interest 1.04 0.82 26.83% 0.99 0.85 16.47% 0.98 0.91 7.69% 0.87 1.00 -13.00%
Depreciation 8.42 8.81 -4.43% 8.98 9.11 -1.43% 8.68 9.31 -6.77% 8.73 9.48 -7.91%
PBT -0.04 -2.12 - 4.38 -1.65 - 4.76 -7.78 - -17.05 13.03 -
Tax 1.95 -0.13 - -0.06 0.55 - 0.05 0.51 -90.20% -1.17 2.05 -
PAT -1.99 -1.99 - 4.44 -2.20 - 4.71 -8.29 - -15.88 10.98 -
PATM -1.50% -1.46% 2.72% -1.46% 3.20% -5.80% -13.72% 8.50%
EPS -0.31 -0.23 - 0.74 -0.36 - 0.78 -1.35 - -2.58 1.79 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 309.85 359.60 257.07 235.50 343.56 489.68 444.16 574.19 530.09 646.90 679.20 Net Sales Growth -13.83% 39.88% 9.16% -31.45% -29.84% 10.25% -22.65% 8.32% -18.06% -4.76% Cost Of Goods Sold 102.70 141.69 163.06 112.09 176.26 150.72 179.70 197.00 168.83 214.35 288.60 Gross Profit 207.15 217.92 94.01 123.42 167.29 338.96 264.46 377.19 361.25 432.55 390.60 GP Margin 66.85% 60.60% 36.57% 52.41% 48.69% 69.22% 59.54% 65.69% 68.15% 66.87% 57.51% Total Expenditure 316.78 345.44 319.69 308.17 343.07 479.63 590.77 492.76 460.60 534.39 611.68 Power & Fuel Cost - 25.33 22.43 26.51 20.78 17.58 22.72 20.94 28.08 24.38 29.89 % Of Sales - 7.04% 8.73% 11.26% 6.05% 3.59% 5.12% 3.65% 5.30% 3.77% 4.40% Employee Cost - 86.53 71.03 72.50 59.47 123.24 141.94 136.74 132.21 139.80 133.23 % Of Sales - 24.06% 27.63% 30.79% 17.31% 25.17% 31.96% 23.81% 24.94% 21.61% 19.62% Manufacturing Exp. - 41.98 27.52 52.73 22.20 14.41 17.46 14.71 34.76 39.10 43.79 % Of Sales - 11.67% 10.71% 22.39% 6.46% 2.94% 3.93% 2.56% 6.56% 6.04% 6.45% General & Admin Exp. - 24.20 18.67 23.59 25.46 15.31 13.95 11.29 36.05 49.77 51.10 % Of Sales - 6.73% 7.26% 10.02% 7.41% 3.13% 3.14% 1.97% 6.80% 7.69% 7.52% Selling & Distn. Exp. - 10.71 12.81 9.26 28.18 10.00 4.09 5.66 36.74 43.79 44.14 % Of Sales - 2.98% 4.98% 3.93% 8.20% 2.04% 0.92% 0.99% 6.93% 6.77% 6.50% Miscellaneous Exp. - 15.01 4.17 11.50 10.71 148.38 210.91 106.42 23.93 23.20 44.14 % Of Sales - 4.17% 1.62% 4.88% 3.12% 30.30% 47.49% 18.53% 4.51% 3.59% 3.08% EBITDA -6.93 14.16 -62.62 -72.67 0.49 10.05 -146.61 81.43 69.49 112.51 67.52 EBITDA Margin -2.24% 3.94% -24.36% -30.86% 0.14% 2.05% -33.01% 14.18% 13.11% 17.39% 9.94% Other Income 16.62 24.91 34.44 12.57 20.75 43.91 8.12 17.62 53.66 25.56 28.05 Interest 15.46 13.78 10.06 7.04 7.52 147.25 104.63 103.23 103.50 115.00 93.17 Depreciation 20.29 21.09 24.50 26.43 26.57 27.29 53.71 57.05 66.15 71.32 65.74 PBT -26.06 4.21 -62.75 -93.58 -12.85 -120.57 -296.83 -61.23 -46.50 -48.25 -63.34 Tax -10.83 0.66 24.79 0.00 1.56 17.10 10.61 10.64 -11.38 0.53 1.89 Tax Rate 41.56% 15.68% -39.51% 0.00% -12.14% -12.58% 28.54% -17.38% 13.54% 37.86% -2.98% PAT -15.23 3.55 -87.54 -93.58 -14.41 -153.07 26.57 -71.88 -72.66 0.87 -65.23 PAT before Minority Interest -15.23 3.55 -87.54 -93.58 -14.41 -153.07 26.57 -71.88 -72.66 0.87 -65.23 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -4.92% 0.99% -34.05% -39.74% -4.19% -31.26% 5.98% -12.52% -13.71% 0.13% -9.60% PAT Growth -529.01% - - - - - - - - - EPS -2.48 0.58 -14.28 -15.27 -2.35 -24.97 4.33 -11.73 -11.85 0.14 -10.64

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 559.09 559.17 459.95 661.23 624.80 544.06 456.70 592.79 544.01 653.08 687.19 Net Sales Growth -0.01% 21.57% -30.44% 5.83% 14.84% 19.13% -22.96% 8.97% -16.70% -4.96% Cost Of Goods Sold 199.54 230.12 252.66 262.20 204.63 156.79 172.24 187.25 149.52 215.81 280.21 Gross Profit 359.55 329.04 207.29 399.03 420.17 387.27 284.45 405.55 394.50 437.27 406.98 GP Margin 64.31% 58.84% 45.07% 60.35% 67.25% 71.18% 62.28% 68.41% 72.52% 66.96% 59.22% Total Expenditure 585.00 579.23 557.90 674.43 548.18 518.57 589.83 508.26 496.89 541.37 643.31 Power & Fuel Cost - 35.95 31.95 37.82 30.94 29.74 34.55 33.52 30.55 25.15 30.73 % Of Sales - 6.43% 6.95% 5.72% 4.95% 5.47% 7.57% 5.65% 5.62% 3.85% 4.47% Employee Cost - 149.57 126.48 182.97 156.17 144.42 147.08 151.59 148.12 142.02 135.98 % Of Sales - 26.75% 27.50% 27.67% 25.00% 26.54% 32.20% 25.57% 27.23% 21.75% 19.79% Manufacturing Exp. - 68.25 47.24 78.70 43.22 33.38 44.31 40.05 41.88 39.47 43.97 % Of Sales - 12.21% 10.27% 11.90% 6.92% 6.14% 9.70% 6.76% 7.70% 6.04% 6.40% General & Admin Exp. - 53.43 43.77 53.79 47.48 54.20 71.07 40.39 52.98 39.41 56.82 % Of Sales - 9.56% 9.52% 8.13% 7.60% 9.96% 15.56% 6.81% 9.74% 6.03% 8.27% Selling & Distn. Exp. - 28.52 42.70 48.08 51.18 42.81 31.27 36.98 37.70 44.20 44.20 % Of Sales - 5.10% 9.28% 7.27% 8.19% 7.87% 6.85% 6.24% 6.93% 6.77% 6.43% Miscellaneous Exp. - 13.39 13.10 10.86 14.56 57.24 89.31 18.48 36.14 35.31 44.20 % Of Sales - 2.39% 2.85% 1.64% 2.33% 10.52% 19.56% 3.12% 6.64% 5.41% 7.48% EBITDA -25.91 -20.06 -97.95 -13.20 76.62 25.49 -133.13 84.53 47.12 111.71 43.88 EBITDA Margin -4.63% -3.59% -21.30% -2.00% 12.26% 4.69% -29.15% 14.26% 8.66% 17.11% 6.39% Other Income 20.66 25.80 51.66 10.97 9.98 30.35 5.06 8.23 46.59 20.35 28.48 Interest 3.88 3.58 4.44 180.84 185.34 173.98 104.83 100.58 100.93 127.33 104.53 Depreciation 34.81 36.71 39.12 43.78 45.59 44.13 55.03 58.53 67.95 73.32 67.24 PBT -7.95 -34.56 -89.86 -226.85 -144.32 -162.28 -287.93 -66.35 -75.17 -68.59 -99.41 Tax 0.77 2.98 46.55 371.02 1.96 16.95 8.56 9.86 -10.98 1.92 3.08 Tax Rate -9.69% 202.72% 363.67% 25.60% -1.36% -9.54% 18.58% -14.86% 16.28% -10.14% -3.10% PAT -8.72 -1.17 -33.23 1,078.31 -146.24 -194.60 37.58 -74.18 -54.75 -18.51 -100.70 PAT before Minority Interest -8.37 -1.50 -33.74 1,078.33 -146.20 -194.63 37.52 -76.20 -56.47 -20.85 -102.49 Minority Interest 0.35 0.33 0.51 -0.02 -0.04 0.03 0.06 2.02 1.72 2.34 1.79 PAT Margin -1.56% -0.21% -7.22% 163.08% -23.41% -35.77% 8.23% -12.51% -10.06% -2.83% -14.65% PAT Growth 0.00% - - - - - - - - - EPS -1.42 -0.19 -5.42 175.91 -23.86 -31.75 6.13 -12.10 -8.93 -3.02 -16.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 329.14 325.65 415.09 508.17 892.73 418.47 388.10 455.82 540.03 539.71 Share Capital 6.13 6.13 6.13 6.13 6.13 6.13 6.13 6.13 22.43 22.43 Total Reserves 323.02 319.53 408.97 502.04 854.61 412.35 381.97 449.69 517.60 517.28 Non-Current Liabilities 346.99 316.77 271.46 254.07 247.15 253.46 748.33 874.35 963.59 809.56 Secured Loans 0.00 0.18 0.24 2.05 6.35 8.90 561.25 704.57 777.88 627.24 Unsecured Loans 124.87 102.22 83.87 60.03 54.08 79.41 9.46 9.49 1.00 1.20 Long Term Provisions 187.29 184.17 184.77 183.84 182.75 183.68 195.31 187.39 184.37 180.42 Current Liabilities 248.99 250.85 244.16 199.52 167.35 921.09 685.27 589.90 474.00 698.70 Trade Payables 122.69 129.12 144.94 124.06 135.90 77.88 241.84 226.75 173.50 186.97 Other Current Liabilities 96.34 92.99 70.35 71.02 24.79 764.16 242.81 142.05 80.88 186.75 Short Term Borrowings 0.00 0.00 0.00 0.00 3.57 69.39 193.82 219.65 218.25 319.83 Short Term Provisions 29.97 28.74 28.86 4.44 3.10 9.66 6.79 1.45 1.37 5.15 Total Liabilities 925.12 893.27 930.71 961.76 1,307.23 1,593.02 1,821.70 1,920.07 1,977.62 2,047.97 Net Block 357.26 385.31 416.13 398.44 447.29 496.44 890.93 942.01 987.58 1,059.68 Gross Block 826.93 852.15 865.20 826.40 863.64 1,087.87 1,542.55 1,536.97 1,518.16 1,532.12 Accumulated Depreciation 469.67 466.84 449.07 427.96 416.36 591.43 651.62 594.95 530.58 472.44 Non Current Assets 741.92 690.25 644.49 669.21 692.91 676.91 1,468.04 1,510.70 1,636.51 1,732.80 Capital Work in Progress 96.54 27.85 0.88 12.97 3.74 3.10 37.16 27.68 19.01 16.98 Non Current Investment 0.27 0.27 0.27 0.27 54.53 2.54 344.88 344.88 394.66 394.66 Long Term Loans & Adv. 221.39 225.33 188.82 187.45 186.50 173.95 194.69 195.57 234.01 260.43 Other Non Current Assets 0.69 1.44 0.49 4.27 0.85 0.89 0.39 0.55 1.25 1.05 Current Assets 183.20 199.13 248.83 292.55 614.32 916.11 353.65 409.37 341.11 315.17 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 107.93 116.10 129.25 87.04 99.23 42.51 149.09 140.60 136.57 140.90 Sundry Debtors 11.08 12.27 23.32 35.29 17.69 25.20 142.27 175.80 142.21 100.43 Cash & Bank 29.43 43.25 42.69 88.96 60.61 7.85 11.79 7.21 9.32 42.37 Other Current Assets 34.75 2.23 2.40 44.36 436.80 840.56 50.50 85.75 53.01 31.47 Short Term Loans & Adv. 31.94 25.28 51.17 36.90 26.95 31.20 40.95 72.01 44.39 23.73 Net Current Assets -65.79 -51.72 4.67 93.03 446.97 -4.98 -331.62 -180.53 -132.89 -383.53 Total Assets 925.12 889.38 893.32 961.76 1,307.23 1,593.02 1,821.69 1,920.07 1,977.62 2,047.97

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 842.05 843.60 876.64 -228.69 198.79 350.40 308.68 355.68 448.61 471.29 Share Capital 6.13 6.13 6.13 6.13 6.13 6.13 6.13 6.13 22.43 22.43 Total Reserves 835.92 837.48 870.51 -234.82 160.66 344.27 302.55 349.55 426.18 448.76 Non-Current Liabilities 265.09 270.70 85.10 959.99 740.66 70.08 591.13 718.78 1,100.11 918.47 Secured Loans 0.00 0.18 0.24 675.05 583.55 8.90 560.45 704.57 866.08 721.77 Unsecured Loans 20.99 19.98 33.87 60.03 29.58 37.22 10.26 9.49 1.00 1.20 Long Term Provisions 199.27 198.02 29.16 30.65 42.74 39.78 26.54 18.36 184.42 180.43 Current Liabilities 308.83 329.73 773.77 449.09 622.14 938.26 695.52 689.13 474.80 706.03 Trade Payables 153.68 177.32 234.72 246.66 198.85 269.71 277.19 248.60 187.87 209.13 Other Current Liabilities 119.33 115.71 503.01 189.06 242.12 585.25 242.00 237.52 93.60 194.85 Short Term Borrowings 0.00 0.00 0.00 0.00 3.57 69.39 164.88 190.71 191.82 295.84 Short Term Provisions 35.82 36.70 36.03 13.37 177.60 13.92 11.44 12.30 1.51 6.21 Total Liabilities 1,412.15 1,440.54 1,732.53 1,177.39 1,558.55 1,355.73 1,592.38 1,774.13 2,024.60 2,099.21 Net Block 569.26 599.95 622.07 608.70 657.39 805.56 948.97 1,001.37 1,071.11 1,144.30 Gross Block 1,311.87 1,330.83 1,313.94 1,266.39 1,282.22 1,392.90 1,605.84 1,600.07 1,620.29 1,633.48 Accumulated Depreciation 742.62 730.88 691.87 657.69 624.84 587.34 656.87 598.70 549.18 489.18 Non Current Assets 926.97 874.32 744.57 666.41 875.27 847.84 1,027.55 1,070.91 1,475.22 1,573.49 Capital Work in Progress 101.50 42.32 17.26 34.42 24.01 22.51 39.92 30.41 115.78 110.31 Non Current Investment 0.07 0.07 0.07 0.07 5.58 5.33 5.25 7.01 5.19 10.20 Long Term Loans & Adv. 242.44 228.23 21.46 17.62 187.70 13.33 28.01 22.03 236.71 262.44 Other Non Current Assets 1.11 3.74 83.71 5.61 0.60 1.12 5.39 10.09 1.26 1.07 Current Assets 485.18 562.32 950.55 510.97 683.27 507.89 564.83 703.22 549.38 525.72 Current Investments 40.36 13.42 5.00 0.00 0.00 0.00 2.03 0.27 3.52 4.98 Inventories 177.94 202.09 212.72 174.14 147.69 81.43 334.21 315.55 305.24 310.22 Sundry Debtors 57.42 60.09 81.66 84.68 68.52 88.73 136.01 142.17 141.67 98.57 Cash & Bank 139.48 225.99 583.28 135.79 89.75 23.48 23.24 14.13 22.93 52.40 Other Current Assets 69.97 8.41 8.75 52.64 377.31 314.25 69.36 231.09 76.02 59.55 Short Term Loans & Adv. 58.00 52.31 59.15 63.72 41.62 41.02 59.30 56.21 66.76 50.15 Net Current Assets 176.34 232.59 176.79 61.88 61.13 -430.38 -130.69 14.08 74.58 -180.31 Total Assets 1,412.15 1,436.64 1,695.12 1,177.38 1,558.54 1,355.73 1,592.38 1,774.13 2,024.60 2,099.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 37.27 -10.74 -52.69 38.27 -82.86 107.16 172.06 103.83 97.85 44.75 PBT 4.21 -62.75 -93.58 -12.88 -135.97 37.18 -61.23 -84.04 1.40 -63.34 Adjustment 30.95 10.43 35.98 31.82 204.95 -67.89 160.40 184.07 133.41 141.57 Changes in Working Capital 4.00 42.67 5.73 20.30 -143.93 137.45 73.35 -2.52 -57.72 -30.18 Cash after chg. in Working capital 39.15 -9.66 -51.87 39.24 -74.96 106.74 172.51 97.51 77.09 48.05 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.88 -1.09 -0.82 -0.98 -7.90 0.42 -0.45 6.32 20.76 -3.30 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -51.01 2.41 39.54 -37.32 -18.52 -8.33 -2.73 -17.92 22.74 -29.24 Net Fixed Assets -43.47 -13.92 -26.71 28.01 223.59 488.74 -15.06 -27.48 11.93 -29.48 Net Investments 0.00 0.00 0.00 54.26 -51.99 342.34 0.00 49.78 0.00 -0.46 Others -7.54 16.33 66.25 -119.59 -190.12 -839.41 12.33 -40.22 10.81 0.70 Cash from Financing Activity 12.82 9.01 9.83 -7.20 109.39 -98.45 -163.67 -91.06 -128.69 -10.88 Net Cash Inflow / Outflow -0.91 0.67 -3.32 -6.26 8.02 0.37 5.66 -5.15 -8.10 4.63 Opening Cash & Equivalents 6.01 5.33 8.66 14.91 4.96 6.52 0.86 6.01 14.13 9.50 Closing Cash & Equivalent 5.09 6.01 5.33 8.66 14.91 4.96 6.52 0.86 6.04 14.13

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -0.10 -422.45 -108.45 106.76 -30.47 104.80 118.02 130.67 90.69 37.23 PBT 1.48 12.81 1,449.36 -145.03 -177.34 46.23 -66.14 -67.18 -18.93 -99.41 Adjustment -8.76 -95.87 -1,454.97 230.88 253.04 -70.58 166.62 149.57 148.75 167.45 Changes in Working Capital 9.69 -336.91 300.86 21.91 -97.50 127.32 21.45 43.32 -58.26 -25.16 Cash after chg. in Working capital 2.41 -419.98 295.25 107.76 -21.80 102.97 121.93 125.71 71.56 42.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.51 -2.48 -403.70 -1.00 -8.67 1.83 -3.91 4.96 19.13 -5.65 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 10.23 430.33 1,282.57 -47.68 -34.76 -5.27 55.29 -25.83 16.44 -37.38 Net Fixed Assets -43.47 -13.92 -26.71 28.01 223.59 488.74 -15.06 -27.48 11.93 -29.48 Net Investments 0.00 0.00 0.00 54.26 -51.99 342.34 0.00 49.78 0.00 -0.46 Others 53.70 444.25 1,309.28 -129.95 -206.36 -836.35 70.35 -48.13 4.51 -7.44 Cash from Financing Activity -2.81 -18.37 -1,175.84 -47.11 90.74 -101.14 -164.35 -106.96 -117.38 -0.70 Net Cash Inflow / Outflow 7.32 -10.49 -1.72 11.97 25.51 -1.61 8.97 -2.13 -10.25 -0.85 Opening Cash & Equivalents 39.85 50.35 52.08 40.22 14.47 16.44 7.47 9.59 19.97 20.84 Closing Cash & Equivalent 47.17 39.85 50.35 52.08 40.22 14.47 16.44 7.47 9.73 19.99

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 53.74 53.17 67.77 82.97 140.53 68.32 63.36 74.42 18.54 18.49 ROA 0.39% -9.57% -9.88% -1.27% -10.56% 1.56% -3.84% -3.73% 0.04% -3.18% ROE 1.08% -23.64% -20.27% -2.11% -23.93% 6.59% -17.03% -25.52% 0.77% -44.62% ROCE 4.08% -11.36% -16.14% -0.70% 1.09% 11.51% 2.96% 1.48% 10.15% 2.58% Fixed Asset Turnover 0.43 0.30 0.28 0.41 0.50 0.34 0.38 0.36 0.42 0.45 Receivable days 11.82 25.11 45.26 27.77 15.98 68.81 100.51 106.68 68.41 51.29 Inventory Days 113.44 173.06 167.03 97.64 52.82 78.73 91.54 92.98 78.23 85.30 Payable days 324.35 306.74 437.99 269.16 104.62 146.14 199.79 153.09 120.20 124.84 Cash Conversion Cycle -199.08 -108.57 -225.70 -143.75 -35.82 1.40 -7.74 46.57 26.45 11.76 Total Debt/Equity 0.38 0.31 0.20 0.13 0.08 1.65 2.50 2.24 7.84 7.83 Interest Cover 1.31 -5.24 -12.29 -0.71 0.08 1.36 0.41 0.19 1.01 0.32

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 137.48 137.73 143.12 -37.34 27.23 57.21 50.40 58.07 -4.43 -0.75 ROA -0.11% -2.12% 74.05% -10.69% -13.36% 2.55% -4.53% -2.97% -1.01% -4.87% ROE -0.18% -3.92% 332.85% 0.00% -75.26% 11.39% -22.94% -34.38% 0.00% -253.03% ROCE 0.59% 1.94% 217.12% 5.36% -0.38% 13.44% 2.63% 2.76% 9.93% 0.45% Fixed Asset Turnover 0.43 0.36 0.54 0.51 0.41 0.30 0.37 0.35 0.40 0.41 Receivable days 37.70 54.62 43.66 42.68 52.75 89.81 85.16 92.84 67.10 51.36 Inventory Days 121.93 159.84 101.55 89.66 76.86 166.09 198.91 203.06 171.89 140.68 Payable days 262.50 297.63 335.05 397.33 178.20 213.56 186.55 163.89 130.73 137.37 Cash Conversion Cycle -102.87 -83.17 -189.84 -264.98 -48.60 42.34 97.52 132.00 108.26 54.67 Total Debt/Equity 0.02 0.02 0.04 -3.58 4.45 1.85 3.05 2.79 -100.22 93.42 Interest Cover 1.41 3.89 9.01 0.22 -0.02 1.44 0.34 0.33 0.85 0.05

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Panacea Biotec bags additional order from UNICEF
24th Apr 2025, 10:22 AM

The company has received order for supply of 40 million doses of its bivalent oral polio vaccine
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback